Anti-PD-1 Antibody Market Report

Global and Region Anti-PD-1 Antibody Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：215
  • REPORT CODE：GMM909003
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Anti-PD-1 Antibody market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Anti-PD-1 Antibodymarket, defines the market attractiveness level of Anti-PD-1 Antibody market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Anti-PD-1 Antibody industry, describes the types of Anti-PD-1 Antibody market, the applications of major players and the market size, and deeply analyzes the current situation of the global Anti-PD-1 Antibody market and the development prospects and opportunities of Anti-PD-1 Antibody industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Anti-PD-1 Antibody market in Chapter 13.

    By Player:

    • Sino Biological Inc

    • 3SBio Inc

    • Thermo Fisher

    • Bristol-Myers Squibb (BMS)

    • Abbvie

    • Ono Pharmaceutical Co, Ltd

    • Abcam

    • Bio X Cell

    • TG Therapeutics, Inc

    • Merck

    • Chugai Pharmaceutical Co, Ltd

    • Lilly

    • Arcus Biosciences

    • InvivoGen

    • Novartis

    • BioVision Inc

    • BeiGene

    By Type:

    • Monoclonal

    • Polyclonal

    By End-User:

    • IHC-P

    • ICC/IF

    • WB

    • Flow Cytometry

    • ELISA

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Anti-PD-1 Antibody Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Anti-PD-1 Antibody Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Anti-PD-1 Antibody Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Anti-PD-1 Antibody Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Anti-PD-1 Antibody Market Analysis and Outlook to 2022

    • 7.1 Global Anti-PD-1 Antibody Consumption (2017-2022)

    • 7.2 United States Anti-PD-1 Antibody Consumption (2017-2022)

    • 7.3 Europe Anti-PD-1 Antibody Consumption (2017-2022)

    • 7.4 China Anti-PD-1 Antibody Consumption (2017-2022)

    • 7.5 Japan Anti-PD-1 Antibody Consumption (2017-2022)

    • 7.6 India Anti-PD-1 Antibody Consumption (2017-2022)

    • 7.7 South Korea Anti-PD-1 Antibody Consumption (2017-2022)

    8 Region and Country-wise Anti-PD-1 Antibody Market Analysis and Outlook to 2028

    • 8.1 Global Anti-PD-1 Antibody Consumption Forecast (2022-2028)

    • 8.2 United States Anti-PD-1 Antibody Consumption Forecast (2022-2028)

    • 8.3 Europe Anti-PD-1 Antibody Consumption Forecast (2022-2028)

    • 8.4 China Anti-PD-1 Antibody Consumption Forecast (2022-2028)

    • 8.5 Japan Anti-PD-1 Antibody Consumption Forecast (2022-2028)

    • 8.6 India Anti-PD-1 Antibody Consumption Forecast (2022-2028)

    • 8.7 South Korea Anti-PD-1 Antibody Consumption Forecast (2022-2028)

    9 Global Anti-PD-1 Antibody Market Outlook by Types and Applications to 2022

    • 9.1 Global Anti-PD-1 Antibody Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Monoclonal Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Polyclonal Consumption and Growth Rate (2017-2022)

    • 9.2 Global Anti-PD-1 Antibody Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global IHC-P Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global ICC/IF Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global WB Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Flow Cytometry Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global ELISA Consumption and Growth Rate (2017-2022)

    10 Global Anti-PD-1 Antibody Market Outlook by Types and Applications to 2028

    • 10.1 Global Anti-PD-1 Antibody Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Monoclonal Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Polyclonal Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Anti-PD-1 Antibody Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global IHC-P Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global ICC/IF Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global WB Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Flow Cytometry Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global ELISA Consumption Forecast and Growth Rate (2022-2028)

    11 Global Anti-PD-1 Antibody Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Anti-PD-1 Antibody Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Anti-PD-1 Antibody Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Anti-PD-1 Antibody Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Anti-PD-1 Antibody Market Competitive Analysis

    • 14.1 Sino Biological Inc

      • 14.1.1 Sino Biological Inc Company Details

      • 14.1.2 Sino Biological Inc Anti-PD-1 Antibody Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Sino Biological Inc Anti-PD-1 Antibody Product and Service

    • 14.2 3SBio Inc

      • 14.2.1 3SBio Inc Company Details

      • 14.2.2 3SBio Inc Anti-PD-1 Antibody Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 3SBio Inc Anti-PD-1 Antibody Product and Service

    • 14.3 Thermo Fisher

      • 14.3.1 Thermo Fisher Company Details

      • 14.3.2 Thermo Fisher Anti-PD-1 Antibody Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Thermo Fisher Anti-PD-1 Antibody Product and Service

    • 14.4 Bristol-Myers Squibb (BMS)

      • 14.4.1 Bristol-Myers Squibb (BMS) Company Details

      • 14.4.2 Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Product and Service

    • 14.5 Abbvie

      • 14.5.1 Abbvie Company Details

      • 14.5.2 Abbvie Anti-PD-1 Antibody Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Abbvie Anti-PD-1 Antibody Product and Service

    • 14.6 Ono Pharmaceutical Co, Ltd

      • 14.6.1 Ono Pharmaceutical Co, Ltd Company Details

      • 14.6.2 Ono Pharmaceutical Co, Ltd Anti-PD-1 Antibody Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Ono Pharmaceutical Co, Ltd Anti-PD-1 Antibody Product and Service

    • 14.7 Abcam

      • 14.7.1 Abcam Company Details

      • 14.7.2 Abcam Anti-PD-1 Antibody Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Abcam Anti-PD-1 Antibody Product and Service

    • 14.8 Bio X Cell

      • 14.8.1 Bio X Cell Company Details

      • 14.8.2 Bio X Cell Anti-PD-1 Antibody Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Bio X Cell Anti-PD-1 Antibody Product and Service

    • 14.9 TG Therapeutics, Inc

      • 14.9.1 TG Therapeutics, Inc Company Details

      • 14.9.2 TG Therapeutics, Inc Anti-PD-1 Antibody Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 TG Therapeutics, Inc Anti-PD-1 Antibody Product and Service

    • 14.10 Merck

      • 14.10.1 Merck Company Details

      • 14.10.2 Merck Anti-PD-1 Antibody Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Merck Anti-PD-1 Antibody Product and Service

    • 14.11 Chugai Pharmaceutical Co, Ltd

      • 14.11.1 Chugai Pharmaceutical Co, Ltd Company Details

      • 14.11.2 Chugai Pharmaceutical Co, Ltd Anti-PD-1 Antibody Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 Chugai Pharmaceutical Co, Ltd Anti-PD-1 Antibody Product and Service

    • 14.12 Lilly

      • 14.12.1 Lilly Company Details

      • 14.12.2 Lilly Anti-PD-1 Antibody Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Lilly Anti-PD-1 Antibody Product and Service

    • 14.13 Arcus Biosciences

      • 14.13.1 Arcus Biosciences Company Details

      • 14.13.2 Arcus Biosciences Anti-PD-1 Antibody Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 Arcus Biosciences Anti-PD-1 Antibody Product and Service

    • 14.14 InvivoGen

      • 14.14.1 InvivoGen Company Details

      • 14.14.2 InvivoGen Anti-PD-1 Antibody Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 InvivoGen Anti-PD-1 Antibody Product and Service

    • 14.15 Novartis

      • 14.15.1 Novartis Company Details

      • 14.15.2 Novartis Anti-PD-1 Antibody Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Novartis Anti-PD-1 Antibody Product and Service

    • 14.16 BioVision Inc

      • 14.16.1 BioVision Inc Company Details

      • 14.16.2 BioVision Inc Anti-PD-1 Antibody Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 BioVision Inc Anti-PD-1 Antibody Product and Service

    • 14.17 BeiGene

      • 14.17.1 BeiGene Company Details

      • 14.17.2 BeiGene Anti-PD-1 Antibody Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 BeiGene Anti-PD-1 Antibody Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Anti-PD-1 Antibody

    • Figure Anti-PD-1 Antibody Picture

    • Table Global Anti-PD-1 Antibody Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Anti-PD-1 Antibody Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Anti-PD-1 Antibody Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Anti-PD-1 Antibody Consumption by Country (2017-2022)

    • Figure United States Anti-PD-1 Antibody Consumption and Growth Rate (2017-2022)

    • Table Europe Anti-PD-1 Antibody Consumption and Growth Rate (2017-2022)

    • Figure China Anti-PD-1 Antibody Consumption and Growth Rate (2017-2022)

    • Figure Japan Anti-PD-1 Antibody Consumption and Growth Rate (2017-2022)

    • Figure India Anti-PD-1 Antibody Consumption and Growth Rate (2017-2022)

    • Figure South Korea Anti-PD-1 Antibody Consumption and Growth Rate (2017-2022)

    • Figure Global Anti-PD-1 Antibody Consumption Forecast by Country (2022-2028)

    • Figure United States Anti-PD-1 Antibody Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Anti-PD-1 Antibody Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Anti-PD-1 Antibody Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Anti-PD-1 Antibody Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Anti-PD-1 Antibody Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Anti-PD-1 Antibody Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Monoclonal Consumption and Growth Rate (2017-2022)

    • Figure Global Polyclonal Consumption and Growth Rate (2017-2022)

    • Figure Global IHC-P Consumption and Growth Rate (2017-2022)

    • Figure Global ICC/IF Consumption and Growth Rate (2017-2022)

    • Figure Global WB Consumption and Growth Rate (2017-2022)

    • Figure Global Flow Cytometry Consumption and Growth Rate (2017-2022)

    • Figure Global ELISA Consumption and Growth Rate (2017-2022)

    • Figure Global Monoclonal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Polyclonal Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global IHC-P Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global ICC/IF Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global WB Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Flow Cytometry Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global ELISA Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Anti-PD-1 Antibody Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Anti-PD-1 Antibody Export by Region (Top 5 Countries) (2017-2028)

    • Table Sino Biological Inc (Foundation Year, Company Profile and etc.)

    • Table Sino Biological Inc Anti-PD-1 Antibody Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sino Biological Inc Anti-PD-1 Antibody Product and Service

    • Table 3SBio Inc (Foundation Year, Company Profile and etc.)

    • Table 3SBio Inc Anti-PD-1 Antibody Sales, Price, Value and Gross Profit (2017-2022)

    • Table 3SBio Inc Anti-PD-1 Antibody Product and Service

    • Table Thermo Fisher (Foundation Year, Company Profile and etc.)

    • Table Thermo Fisher Anti-PD-1 Antibody Sales, Price, Value and Gross Profit (2017-2022)

    • Table Thermo Fisher Anti-PD-1 Antibody Product and Service

    • Table Bristol-Myers Squibb (BMS) (Foundation Year, Company Profile and etc.)

    • Table Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Product and Service

    • Table Abbvie (Foundation Year, Company Profile and etc.)

    • Table Abbvie Anti-PD-1 Antibody Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbvie Anti-PD-1 Antibody Product and Service

    • Table Ono Pharmaceutical Co, Ltd (Foundation Year, Company Profile and etc.)

    • Table Ono Pharmaceutical Co, Ltd Anti-PD-1 Antibody Sales, Price, Value and Gross Profit (2017-2022)

    • Table Ono Pharmaceutical Co, Ltd Anti-PD-1 Antibody Product and Service

    • Table Abcam (Foundation Year, Company Profile and etc.)

    • Table Abcam Anti-PD-1 Antibody Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abcam Anti-PD-1 Antibody Product and Service

    • Table Bio X Cell (Foundation Year, Company Profile and etc.)

    • Table Bio X Cell Anti-PD-1 Antibody Sales, Price, Value and Gross Profit (2017-2022)

    • Table Bio X Cell Anti-PD-1 Antibody Product and Service

    • Table TG Therapeutics, Inc (Foundation Year, Company Profile and etc.)

    • Table TG Therapeutics, Inc Anti-PD-1 Antibody Sales, Price, Value and Gross Profit (2017-2022)

    • Table TG Therapeutics, Inc Anti-PD-1 Antibody Product and Service

    • Table Merck (Foundation Year, Company Profile and etc.)

    • Table Merck Anti-PD-1 Antibody Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Anti-PD-1 Antibody Product and Service

    • Table Chugai Pharmaceutical Co, Ltd (Foundation Year, Company Profile and etc.)

    • Table Chugai Pharmaceutical Co, Ltd Anti-PD-1 Antibody Sales, Price, Value and Gross Profit (2017-2022)

    • Table Chugai Pharmaceutical Co, Ltd Anti-PD-1 Antibody Product and Service

    • Table Lilly (Foundation Year, Company Profile and etc.)

    • Table Lilly Anti-PD-1 Antibody Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lilly Anti-PD-1 Antibody Product and Service

    • Table Arcus Biosciences (Foundation Year, Company Profile and etc.)

    • Table Arcus Biosciences Anti-PD-1 Antibody Sales, Price, Value and Gross Profit (2017-2022)

    • Table Arcus Biosciences Anti-PD-1 Antibody Product and Service

    • Table InvivoGen (Foundation Year, Company Profile and etc.)

    • Table InvivoGen Anti-PD-1 Antibody Sales, Price, Value and Gross Profit (2017-2022)

    • Table InvivoGen Anti-PD-1 Antibody Product and Service

    • Table Novartis (Foundation Year, Company Profile and etc.)

    • Table Novartis Anti-PD-1 Antibody Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Anti-PD-1 Antibody Product and Service

    • Table BioVision Inc (Foundation Year, Company Profile and etc.)

    • Table BioVision Inc Anti-PD-1 Antibody Sales, Price, Value and Gross Profit (2017-2022)

    • Table BioVision Inc Anti-PD-1 Antibody Product and Service

    • Table BeiGene (Foundation Year, Company Profile and etc.)

    • Table BeiGene Anti-PD-1 Antibody Sales, Price, Value and Gross Profit (2017-2022)

    • Table BeiGene Anti-PD-1 Antibody Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US